Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases
- PMID: 24625439
- DOI: 10.1177/1535370213520110
Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases
Abstract
Polymorphonuclear neutrophils (PMN) play a key role in host innate immune responses by migrating to the sites of inflammation. Furthermore, PMN recruitment also plays a significant role in the pathophysiology of a plethora of inflammatory disorders such as chronic obstructive pulmonary disease (COPD), gram negative sepsis, inflammatory bowel disease (IBD), lung injury, and arthritis. Of note, chemokine-dependent signalling is implicated in the amplification of immune responses by virtue of its role in PMN chemotaxis in most of the inflammatory diseases. It has been clinically established that impediment of PMN recruitment ameliorates disease severity and provides relief in majority of other immune-associated disorders. This review focuses on different novel approaches clinically proven to be effective in blocking chemokine signalling associated with PMN recruitment that includes CXCR2 antagonists, chemokine analogs, anti-CXCR2 monoclonal antibodies, and CXCR2 knock-out models. It also highlights the significance of the utility of nanoparticles in drugs used for blocking migration of PMN to the sites of inflammation.
Keywords: CXCR2 antagonists; Chemokine analogs; PMN; integrins; neutrophil infiltration; selectins; transmigration.
Similar articles
-
CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.Eur J Pharmacol. 2011 Oct 15;668(3):443-9. doi: 10.1016/j.ejphar.2011.03.025. Epub 2011 Mar 31. Eur J Pharmacol. 2011. PMID: 21458445
-
Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.J Immunol. 1999 Feb 15;162(4):2341-6. J Immunol. 1999. PMID: 9973513
-
CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice.J Leukoc Biol. 2004 Jul;76(1):58-64. doi: 10.1189/jlb.1103541. Epub 2004 May 3. J Leukoc Biol. 2004. PMID: 15123771
-
CXCR2 antagonists for the treatment of pulmonary disease.Pharmacol Ther. 2009 Jan;121(1):55-68. doi: 10.1016/j.pharmthera.2008.10.005. Epub 2008 Oct 31. Pharmacol Ther. 2009. PMID: 19026683 Review.
-
CXCR2--the receptor to hit?Drug News Perspect. 2006 Dec;19(10):615-23. doi: 10.1358/dnp.2006.19.10.1068009. Drug News Perspect. 2006. PMID: 17299604 Review.
Cited by
-
Neutrophil Infiltration Characterized by Upregulation of S100A8, S100A9, S100A12 and CXCR2 Is Associated With the Co-Occurrence of Crohn's Disease and Peripheral Artery Disease.Front Immunol. 2022 Jun 20;13:896645. doi: 10.3389/fimmu.2022.896645. eCollection 2022. Front Immunol. 2022. PMID: 35795659 Free PMC article.
-
Distinct Spatio-Temporal Dynamics of Tumor-Associated Neutrophils in Small Tumor Lesions.Front Immunol. 2019 Jun 25;10:1419. doi: 10.3389/fimmu.2019.01419. eCollection 2019. Front Immunol. 2019. PMID: 31293583 Free PMC article.
-
Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.Virulence. 2017 Oct 3;8(7):1124-1147. doi: 10.1080/21505594.2017.1303588. Epub 2017 Mar 15. Virulence. 2017. PMID: 28296562 Free PMC article. Review.
-
Boronic acid-containing CXCR1/2 antagonists: Optimization of metabolic stability, in vivo evaluation, and a proposed receptor binding model.Bioorg Med Chem Lett. 2015 Jun 1;25(11):2280-4. doi: 10.1016/j.bmcl.2015.04.041. Epub 2015 Apr 23. Bioorg Med Chem Lett. 2015. PMID: 25933594 Free PMC article.
-
CX3CL1/CX3CR1 Signaling Mediated Neuroglia Activation Is Implicated in the Retinal Degeneration: A Potential Therapeutic Target to Prevent Photoreceptor Death.Invest Ophthalmol Vis Sci. 2024 Jan 2;65(1):29. doi: 10.1167/iovs.65.1.29. Invest Ophthalmol Vis Sci. 2024. PMID: 38231527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources